InsidersTradesSigma
Follow the Accustem Sciences Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, Accustem Sciences Inc. has logged 13 public disclosures. Market capitalisation: €3.3m. The latest transaction was filed on 16 June 2025 (Acquisition). Among the most active insiders: CERRONE GABRIELE M. The full history is openly available.
13
Insider Decl.
n/a
Thresholds
€199,523
13 ops.
Buy Volume
n/a
n/a
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 June 2025
Declarations13 total
2,000 shares@ US$1.000.9% of flowCommon StockSEC:0001641172-25-015197:0
Canonical exit: 11 Sept 2025 (T+90)
28,205 shares@ US$0.394.8% of flowCommon StockSEC:0001641172-25-015003:0
Canonical exit: 9 Sept 2025 (T+90)
35,000 shares@ US$0.66511.3% of flowCommon StockSEC:0001641172-25-003618:0
Canonical exit: 7 Jul 2025 (T+90)
35,000 shares@ US$0.6511.1% of flowCommon StockSEC:0001641172-25-003222:2
Canonical exit: 6 Jul 2025 (T+90)
100,000 shares@ US$0.44721.7% of flowCommon StockSEC:0001641172-25-003222:0
Canonical exit: 16 Jun 2025 (T+90)
17,802 shares@ US$0.6095.3% of flowCommon StockSEC:0001641172-25-003222:1
Canonical exit: 6 Jul 2025 (T+90)
100,000 shares@ US$0.38119.5% of flowCommon StockSEC:0001493152-25-000211:0
Canonical exit: 31 Mar 2025 (T+90)
5,000 shares@ US$1.403.5% of flowCommon StockSEC:0001493152-23-000064:0
Canonical exit: 30 Mar 2023 (T+90)
3,729 shares@ US$1.422.7% of flowCommon StockSEC:0001493152-22-034396:0
Canonical exit: 2 Mar 2023 (T+90)
24,500 shares@ US$1.0513.2% of flowCommon StockSEC:0001493152-22-033239:0
Canonical exit: 16 Feb 2023 (T+90)
10,000 shares@ US$0.794.1% of flowCommon StockSEC:0001493152-22-020942:0
Canonical exit: 30 Oct 2022 (T+90)
20,000 shares@ US$0.500.18% mcap63.9% of flowCommon StockSEC:0001493152-22-016256:0
Canonical exit: 6 Sept 2022 (T+90)
4,181 shares@ US$1.350.10% mcap36.1% of flowCommon StockSEC:0001493152-22-011318:0
Canonical exit: 24 Jul 2022 (T+90)
13 of 13 declarations
Acerca de Accustem Sciences Inc.
Accustem Sciences Inc. es una empresa centrada en el desarrollo de soluciones de diagnóstico para el cáncer. Su objetivo es mejorar los métodos para detectar y monitorear enfermedades oncológicas.